Cannabis exposure during pregnancy and perinatal outcomes: A cohort study DOI Creative Commons
Maia Brik, Miguel Sandonis, Alina Hernández‐Fleury

и другие.

Acta Obstetricia Et Gynecologica Scandinavica, Год журнала: 2024, Номер 103(6), С. 1083 - 1091

Опубликована: Март 19, 2024

Abstract Introduction Cannabis potency and its use during pregnancy have increased in the last decade. The aim of this study was to investigate impact antenatal cannabis on fetal growth, preterm birth other perinatal outcomes. Material methods A propensity score‐matched analysis performed women with singleton pregnancies attending a tertiary care site Barcelona. Women group were selected based results detection test. Primary outcomes small for gestational age at (SGA), low birthweight birth. Secondary biometric parameters (neonatal length head circumference), respiratory distress, admission neonatal intensive unit breastfeeding discharge. second excluding confounders (use recreational drugs discontinuation pregnancy) performed. Results Antenatal associated higher odds ratio SGA (OR 3.60, 95% CI: 1.68–7.69), 3.94, 2.17–7.13), 37 weeks 2.07, 1.12–3.84) 32 gestation 4.13, 1.06–16.11), 1.95, 1.03–3.71), distress 2.77, 1.26–6.34), lower rates discharge 0.10, 0.05–0.18). When confounders, no significant association between found. Conclusions increases risk SGA, birthweight, adverse However, when isolating by who those discontinue pregnancy,

Язык: Английский

Prenatal Cannabis Use and Maternal Pregnancy Outcomes DOI
Kelly C. Young‐Wolff, Sara R. Adams, Stacey E. Alexeeff

и другие.

JAMA Internal Medicine, Год журнала: 2024, Номер 184(9), С. 1083 - 1083

Опубликована: Июль 22, 2024

Many studies have evaluated whether in utero cannabis exposure is associated with fetal and neonatal outcomes, yet little known about prenatal use maternal health outcomes during pregnancy.

Язык: Английский

Процитировано

14

Prenatal Opioid Exposure and Risk for Adverse Brain and Motor Outcomes in Infants Born Premature DOI Creative Commons
E. Melinda Mahabee‐Gittens, Venkata Sita Priyanka Illapani, Stephanie L. Merhar

и другие.

The Journal of Pediatrics, Год журнала: 2024, Номер 267, С. 113908 - 113908

Опубликована: Янв. 21, 2024

Язык: Английский

Процитировано

7

Patient Perceptions of Prenatal Cannabis Use and Implications for Clinicians DOI
Tara R. Foti,

Andrea Green,

Andrea Altschuler

и другие.

Obstetrics and Gynecology, Год журнала: 2023, Номер unknown

Опубликована: Авг. 10, 2023

OBJECTIVE: To understand pregnant patients' reasons for prenatal cannabis use and perceptions of safety, desired undesirable health care experiences, information about secondarily to racial differences in these preferences. METHODS: We conducted a qualitative study including 18 semi-structured, race-concordant virtual focus groups with individuals who self-reported at entry large integrated system Northern California from November 2021 December 2021. The included semi-structured questions that were recorded, transcribed, coded by the research team. Thematic analysis was used analyze data. RESULTS: Overall, 53 participants included; 30 self-identified, as White 23 self-identified Black. Participants averaged 30.3 years age (SD 5.2 years) on average 20.9 weeks gestation enrollment; 69.8% reported daily use, 24.5% weekly 5.7% monthly or less entrance care. Although some quit early pregnancy because concerns potential risks, many perceived lack scientific evidence believed safe. Many preferred over-the-counter prescription medications treating mood, morning sickness, pain, sleep. valued open interactions obstetricians acknowledged their motivations they risks through conversations educational materials. Black participants' perspectives generally similar, but few uniquely described bias related use. CONCLUSION: Pregnant patients manage mood medical symptoms, safer than medications. Obstetrician-initiated, patient-centered around advice discontinue during pregnancy, exploration willingness switch medically recommended interventions pregnancy-related symptoms may benefit patients.

Язык: Английский

Процитировано

17

Neonatal outcomes associated with in utero cannabis exposure: a population-based retrospective cohort study DOI
Lyndsay A. Avalos, Sara R. Adams, Stacey E. Alexeeff

и другие.

American Journal of Obstetrics and Gynecology, Год журнала: 2023, Номер 231(1), С. 132.e1 - 132.e13

Опубликована: Ноя. 27, 2023

Язык: Английский

Процитировано

15

Cannabis use, decision making, and perceptions of risk among breastfeeding individuals: the Lactation and Cannabis (LAC) Study DOI Creative Commons
Caroline B. Smith, J. J. E. Schmidt, Elizabeth A. Holdsworth

и другие.

Journal of Cannabis Research, Год журнала: 2024, Номер 6(1)

Опубликована: Фев. 16, 2024

Our primary objective was to understand breastfeeding individuals' decisions use cannabis. Specifically, we investigated reasons for cannabis use, experiences with healthcare providers regarding and potential concerns about use.

Язык: Английский

Процитировано

5

Human Milk Cannabinoid Concentrations and Associations with Maternal Factors: The Lactation and Cannabis (LAC) Study DOI
Elizabeth A. Holdsworth, Anna Berim, David R. Gang

и другие.

Breastfeeding Medicine, Год журнала: 2024, Номер 19(7), С. 515 - 524

Опубликована: Май 2, 2024

As cannabis use increases among reproductive-aged women, there is a growing need to better understand the presence of cannabinoids in milk produced by women using cannabis. It unclear how concentrations such as delta-9-tetrahydrocannabinol (Δ

Язык: Английский

Процитировано

5

Prenatal cannabis exposure and the risk for neuropsychiatric anomalies in the offspring: a systematic review and meta-analysis DOI

Hely Bassalov,

Noa Yakirevich-Amir,

Inbal Reuveni

и другие.

American Journal of Obstetrics and Gynecology, Год журнала: 2024, Номер 231(6), С. 574 - 588.e8

Опубликована: Июнь 20, 2024

Язык: Английский

Процитировано

5

Oral pre‐ and early postnatal cannabis exposure disinhibits ventral tegmental area dopamine neuron activity but does not influence cocaine preference in offspring in mice DOI Creative Commons
Colleen Peterson, Samantha L. Baglot, Nada A. Sallam

и другие.

Journal of Neuroscience Research, Год журнала: 2024, Номер 102(7)

Опубликована: Июль 1, 2024

Abstract Cannabis consumption has increased from 1.5% to 2.5% in Canada between 2012 and 2019. Clinical studies have indicated effects of prenatal cannabis exposure on birth weight, substance use, neurodevelopmental disorders, but are confounded by several difficult control variables. Animal models allow for examination the mechanism cannabis‐induced changes neurodevelopment behavior, while controlling dose timing. Several animal exist which provide varying levels construct validity, dose, maternal stress. Using a voluntary oral model, mouse dams received 5 mg/kg Δ9‐tetrahydrocannabinol (THC) whole oil peanut butter daily gestational day 1 (GD1) postnatal 10 (PD10). At GD1, GD18, PD1, PD10, PD15, plasma was collected; pup brains were collected GD18 onward. Pup had higher THC cannabidiol at each time point, persisted past end treatment (PD15). Male female adolescent offspring examined ventral tegmental area (VTA) dopamine neuron activity cocaine‐seeking behavior. Prenatal early (GD1–PD10) cannabis‐exposed male, not mice decreased gamma‐aminobutyric acid (GABAergic) input, depolarized resting membrane potential, spontaneous firing VTA neurons. Cannabis‐exposed showed faster decay N‐methyl‐D‐aspartate (NMDA) currents both sexes. However, no differences behavior noted. These data characterize model demonstrates neuronal is disinhibited offspring.

Язык: Английский

Процитировано

5

Cannabis Use During Early Pregnancy Following Recreational Cannabis Legalization DOI Creative Commons
Kelly C. Young‐Wolff, Natalie E. Slama, Lyndsay A. Avalos

и другие.

JAMA Health Forum, Год журнала: 2024, Номер 5(11), С. e243656 - e243656

Опубликована: Ноя. 1, 2024

It is unknown whether state recreational cannabis legalization (RCL) related to increased rates of prenatal use or RCL-related changes vary with screening methods the local policy environment.

Язык: Английский

Процитировано

4

An epigenetic synopsis of parental substance use DOI
Jamie O. Lo, R D'mello,

Lester Watch

и другие.

Epigenomics, Год журнала: 2023, Номер 15(7), С. 453 - 473

Опубликована: Апрель 1, 2023

The rate of substance use is rising, especially among reproductive-age individuals. Emerging evidence suggests that paternal pre-conception and maternal prenatal may alter offspring epigenetic regulation (changes to gene expression without modifying DNA) outcomes later in life, including neurodevelopment mental health. However, relatively little known due the complexities limitations existing studies, making causal interpretations challenging. This review examines contributions influence parental on gametes potential transmissibility offspring's epigenome as possible areas target public health warnings healthcare provider counseling individuals or couples periods ultimately mitigate short- long-term morbidity mortality.

Язык: Английский

Процитировано

9